The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Neonatal ThrombocytopeniaBleeding
Trial Locations (8)

84107

NOT_YET_RECRUITING

Intermountain Medical Center, Murray

84604

NOT_YET_RECRUITING

Utah Valley Hospital, Provo

02115

RECRUITING

Boston Children's Hospital, Boston

02215

NOT_YET_RECRUITING

Beth Israel Deaconess Medical Center, Boston

Unknown

NOT_YET_RECRUITING

Amsterdam University Medical Centre, Amsterdam

NOT_YET_RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Karolinska University Hospital Huddinge campus, Huddinge

RECRUITING

Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Boston Children's Hospital

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

Region Stockholm

OTHER_GOV

collaborator

The Swedish Society of Medicine

OTHER

lead

Karolinska Institutet

OTHER